No Detail Found!

Efficacy and safety of intensive desferal [deferoxamine] infusion in thalassemia associated iron overload.

Author(s)
Tazeen Anwar Thalassemia Centre, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Naila Yaqub Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Zahoor Ahmad Maryam Memorial Hospital, Peshawar road, Rawalpindi, Pakistan
Abstract
To see the efficacy and safety of intensive deferoxamine [DFO] infusion in blood transfusion associated iron overload in thalassemia major patients. Materials and Methods. This hospital based observational study was conducted at thalassemia centre, PIMS over a period of 3 years from January 2009 to Dec.2012.Those thalasemics having serum ferritin more than 3000ng/l inspite of taking defrasirox orally or subcutaneous deferoxamine were included. They received intravenous infusion of defroxamine[DFO] 50mg/kg over 24 hours for 10 consecutive days. Serum ferritin was measured at 0,6,12,18 months of study to see the efficacy of this regimen. Close monitoring was done to see any adverse effect during this infusion. Results: Serum ferritin ranged from 3050ng/l to 13600ng/l[mean 5939ng/l] at baseline for 48 patients enrolled in this study.Serum ferritin 6 month after intensive regimen ranged from 990ng/l to 13000ng/l][mean 4113ng/l].It was from 1079ng/l to 13000ng/l[mean 3769ng/l] and 1360ng/l to 7250ng/l [4132ng/l] at 12 and 18 months after this infusion respectively. Conclusion: In our study mean serum ferritin decreased from 5953ng/ml to 4119ng/ml[30%reduction] p value
Publication Details
Page(s) 195-197
DOI DOI not available
Published Journal: Annals of the Pakistan Institute of Medical Sciences, Volume: 9, Issue: 4, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

81

Views